The plaintiff sued the defendant pharmaceutical company for negligence, alleging that its prescription inhaler, Symbicort, caused him to develop a rare disease, EGPA.
The defendant moved for summary judgment on the basis that the plaintiff could not prove general causation.
The court accepted the uncontradicted expert evidence that while there is an epidemiological association between the drug and the disease, there is no causal connection.
Finding no genuine issue requiring a trial, the court granted the motion and dismissed the action.
